Oramed Pharmaceuticals is a pharmaceutical company. Co. is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Co.'s primary product, ORMD-0801, is an orally ingestible insulin capsule for the treatment of diabetes. In addition to its key product, the ORMD-0801 insulin capsule, Co. is using its technology for an orally ingestible Glucagon-like peptide-1 capsule, or ORMD-0901. Co. is developing a drug candidate, a weight loss treatment in the form of an oral leptin capsule. We show 45 historical shares outstanding datapoints in our ORMP shares outstanding history coverage, used to compute ORMP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ORMP market cap history over the course of time is important for investors
interested in comparing ORMP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ORMP versus a peer is one thing; comparing
ORMP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ORMP can fluctuate over the course of history.
With this page we aim to empower investors researching ORMP by allowing them to research the ORMP market cap history. |
Free ORMP Email Alerts:
Video: The Importance of Market Cap
